13
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T17731L |
CL2A-SN-38 DCA 1279680-68-0(free base)
|
Others | Others |
CL2A-SN-38 DCA 1279680-68-0(free base) 是一种药物-接头偶联物,由有效的 DNA 拓扑异构酶 I 抑制剂 SN-38 和接头 CL2A 组成,用于制造抗体药物偶联物 (ADC)。CL2A-SN-38 由有效的 DNA 拓扑异构酶组成I 抑制剂 SN-38 和接头 CL2A 以制造抗体药物偶联物 (ADC)。 CL2A-SN-38 对一系列人类实体瘤类型提供显着和特异性的抗肿瘤作用。 CL2A 是一种不可切割的复杂 PEG8 和含有三唑的 PABC-肽-mc 接头。 CL2A 可通过 pH 敏感性裂解,产生旁观者效应,并通过二硫键在半胱氨酸残基处结合抗体。 | |||
T13538 |
AlbA-DCA
|
ROS | Immunology/Inflammation |
AlbA-DCA is a conjugate formed by the attachment of Albiziabioside A to a dichloroacetate acid subunit. It can induce a marked increase in intracellular ROS and alleviate the accumulation of lactic acid in the tumor microenvironment, and also selectively | |||
T27551 |
Honokiol DCA
Honokiol Bis-Dichloroacetate |
||
Honokiol DCA is an inhibitor of DRP1 phosphorylation. Honokiol DCA stimulates a phenotype suggestive of respiration through mitochondrial normalization and demonstrating activity in Vemurafenib-resistant melanoma in vivo. | |||
T60400 |
LDCA
|
Apoptosis; Dehydrogenase | Apoptosis; Metabolism |
LDCA 是一种双hit 代谢调节剂,展现出强大的抗增殖活性。LDCA 能竞争性地抑制LDH-A 酶的活性,改变线粒体的超极化并同时颠覆细胞凋亡。LDCA 在癌细胞中作用明显且不显示出毒性。 | |||
T23969 |
DCAI
|
Others | Others |
DCAI 是一种核苷酸交换和核苷酸释放的抑制剂,通过与 Ras-SOS 界面附近的口袋结合而起作用。 | |||
T81788 | Mito-SilylDCA | ||
Mito-SilylDCA 是一种针对线粒体网络中的 PDK1 的丙酮酸氢酶激酶抑制剂。这种化合物结合了具有靶向 TPP 部分的 DCA 分子,以及聚乙烯长链与硅基,以实现其对 PDK1 的抑制作用。 | |||
T27127 |
DCAT Maleate
DCAT |
||
DCAT Maleate is an inhibitor of N-methyl transferases (NMT). DCAT Maleate methylate non-methylated pre-neurotoxins to prevent the formation of Parkinson's syndrome neurotoxins. | |||
T82603 | DCAF1 binder 2 | ||
DCAF1 binder 2 是 E3 Ligase 的配体,涉及 BRD9、激酶和选择性 BTK 降解。 | |||
T77965 |
DCAF1 binder 1
|
||
DCAF1 binder 1 是针对 CRL4 DCAF1 E3 连接酶复合物的选择性 ligands for E3 Ligase,旨在用于靶向蛋白质降解 (TPD)。 | |||
T72006 |
DCAI Hydrochloride
|
||
DCAI hydrochloride is an inhibitor of nucleotide exchange and nucleotide release, by binding to the pocket adjacent to the Ras-SOS interface. | |||
T14778 |
BRD6989
|
IL Receptor; CDK; Interleukin | Cell Cycle/Checkpoint; Immunology/Inflammation |
BRD6989 是天然产物皮质抑素 A 的类似物,可抑制CDK8并上调IL-10,抑制重组 CDK8 或 CDK19 复合物的激酶活性。它选择性结合 CDK8 复合物,IC50约为 200 nM。 | |||
T27537 |
Hexafluoro
|
||
Hexafluoro is an inhibitor of DRP1 phosphorylation. Honokiol DCA stimulates a phenotype suggestive of respiration through mitochondrial normalization and demonstrates activity in Vemurafenib-resistant melanoma in vivo. | |||
T37355 |
CAY10703
|
||
Dichloroacetate (DCA) is an inhibitor of all pyruvate dehydrogenase kinase (PDHK) isoforms, which are enzymes that phosphorylate and inhibit PDH in mitochondria. Inhibition of PDHK shifts cell metabolism from glycolysis to mitochondrial glucose oxidation, an effect that has relevance to cancer, type 2 diabetes, and other diseases. CAY10703 is a DCA trimer that is at least 10-fold more cytotoxic against leukemia cell lines than DCA. It is approximately 3-fold less cytotoxic than DCA against perip... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3604 |
Sodium dichloroacetate
Sodium Dichloroacetate,DCA,BCA,bichloroacetic acid,二氯乙酸钠,Sodium dichloroacetate (DCA),二氯醋酸酯 |
Apoptosis; Dehydrogenase; Reactive Oxygen Species; PDK | Apoptosis; Immunology/Inflammation; Metabolism; NF-κB; PI3K/Akt/mTOR signaling |
Sodium dichloroacetate (BCA) 是癌细胞线粒体中的一种代谢调节剂,具有抗癌活性。它抑制丙酮酸脱氢酶激酶,从而导致肿瘤微环境中的乳酸减少。它增加活性氧的产生并促进癌细胞凋亡,还可作为NKCC 抑制剂。 | |||
TN6015 |
N-Methyllindcarpine
2,11-Dihydroxy-1,10-dimethoxyaporphine |
||
N-Methyllindcarpine是一种天然产物,属于樟科山胡椒属,其产品编号为 TN6015,CAS号为 14028-97-8。N-Methyllindcarpine可用作对照参考。 | |||
T36585 |
Isodeoxycholic Acid
isoDCA |
Chloride channel; Antibacterial | Membrane transporter/Ion channel; Microbiology/Virology |
Isodeoxycholic Acid 是一种胆汁酸,由肠道细菌通过脱氧胆酸的表聚作用形成。Isodeoxycholic acid 的临界胶束浓度高于二氯苯甲醚,这表明它的去污活性降低了,而且在抑制七种肠道共生细菌生长方面的活性低于二氯苯甲醚。Isodeoxycholic Acid(0.1%)能抑制几种艰难梭菌菌株在牛磺胆酸诱导下的孢子萌发,并能降低艰难梭菌培养上清对 Vero 细胞的细胞毒性。在高脂饮食诱发肥胖的大鼠模型中,血浆中的Isodeoxycholic acid 水平比正常饮食的大鼠低。 |